Furthermore, transwell experiments demonstrated that knocking down APOBEC3C using siRNA technology under in‐vitro conditions could significantly inhibit the migration and invasion abilities of glioma cells (Figure 11F). The gene discussed is APOBEC3C; the disease is central nervous system cancer.